enloplatin has been researched along with Ovarian Neoplasms in 1 studies
*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, CL; Freedman, RS; Hord, M; Kavanagh, JJ; Kim, EE; Kudelka, AP; Madden, TL; Mante, R; Rastogi, R; Siddik, ZH; Tornos, C; Tresukosol, D | 1 |
1 trial(s) available for enloplatin and Ovarian Neoplasms
| Article | Year |
|---|---|
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Glomerular Filtration Rate; Humans; Metabolic Clearance Rate; Middle Aged; Ovarian Neoplasms; Patient Selection; Survival Rate | 1997 |